1/21
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
P. Jirovecii
What organism causes PJP/PCP in humans?
During early childhood; ⅔ of children 2-4 years of age have antibodies
The PJP initial infection usually occurs _____ and________
Spreads via airborne route
Used to occur in 70-80% of people with advanced HIV (before prophylaxis)
20-40% mortality rate
90% of cases patients have CD4 <200
Other PCP/PJP Epidemiology Points 1
Incidence has gone down due to PCP prophylaxis and ART
Current incidence: <1 case per 100 person-years
Most cases are now ppl who are unaware of HIV status or not receiving care or advanced immunosuppression (CD4 <100)
Other PJP/PCP Epidemiology Points 2
Dyspnea
Fever (main symptom)
Non-productive cough
Chest discomfort that worsens within days to weeks
Main clinical manifestations of PJP/PCP
Hypoxemia
Mild: PaO2 >70 or A-a gradient <35
Moderate: A-a gradient >35 to <45
Severe: A-a gradient >45
What is the main lab abnormality of PCP/PJP?
Lactate dehydrogenase >500 is common
People with HIV may also have other pulmonary dysfunction (TB, kaposi sarcoma, toxoplasmosis)
Sometimes ppl with infection can have normal chest x ray, can use CT
Other clinical manifestations / lab abnormalities of PJP/PCP
CD4 100-200, if plasma HIV RNA level above detection limits OR
CD4 <100, regardless of plasma HIV RNA levels
SO
start PPX with Bactrim 160/800 or 80/400 IF CD4 100-200 (HIV RNA level above limit) OR if CD4 < 100
Indication for Primary PPX
Bactrim (TMP/SMX) 1 DS (160/800mg) tablet po daily OR 1 SS (80/400mg) tab po daily
Preferred (1st line) PPX treatment of PJP/PCP
Bactrim DS
Dapsone w pyrimethamine + leucovorin
Atovaquone
B // DPL // A
Alternative primary PPX therapy for patients who are positive OR negative for toxoplasma
Dapsone
Pentamidine (nebulizer or IV)
D // P
Alternative primary PPX therapy for patients who are negative for toxoplasma
CD4 increased from <200 to 200 cells or more for >3 months in response to ART
Can consider if CD4 100-200 and HIV RNA remains below detection limit for >3-6 months
When would you discontinue PJP/PCP PRIMARY PPX?
Bactrim (TMP-SMX): 15-20mg/kg/day (TMP) and 75-100mg/kg/day (SMX) IV q6-8 hours
Can switch to oral once clinical improvement
Treatment (not PPX) of Moderate to severe PJP/PCP - PREFERRED THERAPY
Primaquine + clindamycin
Pentamidine
Treatment (not PPX) of Moderate to severe PJP/PCP - ALTERNATIVE THERAPY
Corticosteroids IF:
PaO2 <70 at room air OR
A-a gradient > or equal to 35
Prednisone taper
Days 1-5—-> 40mg po bid
Days 6-10 —> 40mg po daily
Days 11-21—> 20mg po daily
Treatment (not PPX) of Moderate to severe PJP/PCP - ADJUNCTIVE THERAPY
Bactrim (TMP-SMX): 15-20mg/kg/day (TMP) and 75-100mg/kg/day (SMX) IV q6-8 hours
OR
Bactrim (TMP/SMX) two DS tabs PO TID
Treatment (not PPX) of Mild to Moderate PJP/PCP - PREFERRED THERAPY
Dapsone
Primaquine + clindamycin
Atovaquione
D // PC // A
Treatment (not PPX) of Mild to Moderate PJP/PCP - Alternative THERAPY
21 days for all regimens
initiate secondary pox after tx is complete
Treatment duration of PCP/PJP Treatment (not PPX)
ART should be initiated within 2 weeks of PCP diagnosis
People with HIV should be closely followed for recurrence symptoms after initiation of ART
ART considerations PJP/PCP
immediately upon successful completion of PCP therapy and maintained until immune reconstitution occurs as a result of ART
Can use
dapsone
dapsone + pyrimethamine +leucovorin,
atovaquone, or
pentamidine if HIV patient is intolerant to TMP-SMX
TMP-SMX IS PREFERRED TX
When should secondary PCP/PJP PPX be STARTED?
Adults w/ CD4 increased to >200 or more for >3 months as a result of ART
Can potentially d/c in patients with HIV with CD4 100-200 AND HIV levels are below detection for 3-6 months
When should secondary PCP/PJP PPX be STOPPED?
If CD4 decreases to <100 regardless of HIV viral load
Ppl with CD4 100-200 w/ HIV viral load above detection limits
If PCP episode occurs for pt. w/ CD4 >200 while the pt. Is on ART, continue prophylaxis for life regardless of CD4 cell count rising
When should secondary PCP/PJP PPX be RESTARTED?